Skip to main content

MDPV Facts

Stimulant; Substituted cathinone; Dopamine reuptake inhibitor

Description

MDPV (3,4-methylenedioxypyrovalerone) is a synthetic stimulant of the pyrrolidinophenone class. It blocks dopamine and norepinephrine reuptake in the brain, driving intense stimulation.[1]

Subjective effects include intense euphoria, psychomotor stimulation, wakefulness, heightened motivation, and sharp focused drive. The experience is almost purely dopaminergic — raw stimulant energy without the emotional warmth of substances like MDMA, and the high tips rapidly toward paranoid dysphoria with repeated doses.[2]

MDPV carries extreme abuse liability and high acute toxicity; multiple deaths are confirmed, including one at a blood level far below typical recreational use.[3] Acute psychosis occurs in 26–40% of emergency presentations,[4] and compulsive redosing rapidly escalates into cardiovascular and psychiatric crisis.

Dose and durationby route · individual sensitivity varies

Oral(mg)
Threshold< 2 mgLight4 – 8 mgCommon8 – 14 mgStrong14 – 25 mgHeavy25+ mg

Starts in 15 – 30 minLasts 2 – 7 hoursAfter-effects 2 – 48 hours

Body and dependence

Acute toxicity
High
Chronic toxicity
Moderate
Physical dependence
Low
Psychological dependence
High
Withdrawal
Moderate
Compulsive redosing
High

Tolerance

Builds
Rapid
Fully resets after
Not recorded
Carries over to
cocaine; methylphenidate; alpha-PVP; MDPHP

Effectslikely at a common dose

Perception
Dreaming suppression
Body
Stimulation; Appetite suppression; Restlessness; Abnormal heartbeat; Wakefulness; Pupil dilation; Vasoconstriction; +14 possible, including Heart rate perception changes, Insomnia, Muscle tension
Thinking
Compulsive redosing urge; +10 possible, including Cognitive dysphoria, Confusion, Thought disorganization
Feeling
Anxiety; +7 possible, including Paranoia, Depression, Anhedonia
Self
none likely · 5 possible, including Craving, Ego inflation, Compulsive repetitive behavior

Who shouldn't take it

Absolute
Pre-existing cardiovascular disease; Psychotic disorders; Pregnancy
Relative
Epilepsy; Bipolar disorder; Hepatic impairment; Renal impairment

Combinations62 recorded

Lethal (2)
Ibogaine; Tramadol
Dangerous (29)
Alpha-2 adrenergic receptor antagonist; Amphetamines; Benzodiazepines, Barbiturates; Ephedrine, Pseudoephedrine; Local anesthetics; MAOIs; MDMA, Amphetamines; MDMA, MDA; NDRIs (Wellbutrin); NRIs; Opioids; SSRIs; Stimulants; Anticholinergics; Antipsychotics; Buspirone; Caffeine; Dopamine agonists; DXM; GHB, Baclofen; GHB, GBL; Ketamine, DXM, PCP; Lithium; NSAIDs; and 5 more, see full page
Caution (28)
See full page: psychedex.org/substances/mdpv
Not graded (3)
Not listed never means safe.

Seek help immediately if

  • Chest pain; racing, pounding, or irregular heartbeat
  • Very high body temperature; heavy sweating; hot, flushed skin
  • Severe agitation, paranoia, panic, or confusion
  • Severe headache; muscle rigidity or twitching
  • Seizures
  • Signs of stroke — face drooping, one-sided weakness, slurred speech
  • Difficulty breathing; collapse or unconsciousness

What to do

  1. Call emergency services for chest pain, overheating, seizure, or unresponsiveness
  2. Move them to a cool, quiet place and reduce stimulation
  3. Cool the body — remove excess clothing, apply cool damp cloths, fan them
  4. Keep them calm; reassure — panic worsens the cardiovascular strain
  5. If seizing, protect from injury (don't restrain); recovery position afterward
  6. Monitor breathing and be ready to give rescue breaths / CPR

Most stimulant overdoses settle with cooling, a calm environment, and time. The medical danger is hyperthermia, cardiac events (arrhythmia, heart attack, stroke), and seizures — get help immediately if any appear.

988 Suicide & Crisis LifelineFireside Project: 62-FIRESIDE

Version r1 · Not medical advice

References

  1. [1]
    ^Simmler LD, Buser TA, Donzelli M, et al. (2012) Pharmacological characterization of designer cathinones in vitro — British Journal of Pharmacology doi:10.1111/j.1476-5381.2012.02145.x
  2. [2]
    ^Watterson LR, Kufahl PR, Nemirovsky NE, Sewalia K, Grabenauer M, Thomas BF, Marusich JA, Wegner S, Olive MF (2014) Potent rewarding and reinforcing effects of the synthetic cathinone 3,4-methylenedioxypyrovalerone (MDPV) — Addiction Biology doi:10.1111/j.1369-1600.2012.00474.x
  3. [3]
    ^Desharnais B, Dazé Y, Huppertz LM, Mireault P, Skinner CD (2017) A case of fatal idiosyncratic reaction to the designer drug 3,4-methylenedioxypyrovalerone (MDPV) and review of the literature — Forensic Science, Medicine, and Pathology doi:10.1007/s12024-017-9894-1
  4. [4]
    ^Murphy CM, Dulaney AR, Beuhler MC, Kacinko S (2013) 'Bath salts' and 'plant food' products: the experience of one regional US poison center — Journal of Medical Toxicology doi:10.1007/s13181-012-0243-1
Print version
Report an issue